|
|
| | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate Basic information |
| Product Name: | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate | | Synonyms: | Parecoxib impurity 18/Ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate;Parecoxib Sodium Impurity 25(Not Continue);Parecoxib impurity M: ethyl sulfonate;Parecoxib Sodium-23;Parecoxib Impurity8;Benzenesulfonic acid, 4-(5-methyl-3-phenyl-4-isoxazolyl)-, ethyl ester;4-(5-Methyl-3-phenyl-4-isoxazolyl)-ethyl Ester Benzenesulfonic Acid;Ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate (Palbociclib Impurity) | | CAS: | 1884279-18-8 | | MF: | C18H17NO4S | | MW: | 343.4 | | EINECS: | | | Product Categories: | | | Mol File: | 1884279-18-8.mol |  |
| | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate Chemical Properties |
| Boiling point | 464.6±45.0 °C(Predicted) | | density | 1.239±0.06 g/cm3(Predicted) | | pka | -3.41±0.50(Predicted) |
| | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate Usage And Synthesis |
| Uses | 4-(5-Methyl-3-phenyl-4-isoxazolyl)-ethyl Ester Benzenesulfonic Acid is an impurity of Parecoxib Sodium (P193275) which is an anti-inflammatory, analgesic. |
| | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate Preparation Products And Raw materials |
|